Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study
about
Factors affecting time to maintenance dose in patients initiating warfarin.Patient adherence to warfarin therapy and its impact on anticoagulation controlPractical management approaches to anticoagulation non-compliance, health literacy, and limited English proficiency in the outpatient clinic setting.Dabigatran etexilate: a pharmacoeconomic review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.Pharmacologic and nonpharmacologic thromboprophylactic strategies in atrial fibrillation.Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study.Association Between Patient-Reported Medication Adherence and Anticoagulation Control.Predicting prolonged dose titration in patients starting warfarin.Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.Comparison of three medication adherence measures in patients taking warfarin.Adherence with health regimens of patients on warfarin therapy.Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program.Association between satisfaction with and adherence to warfarin therapy on the control of international normalized ratio: A hospital-based study in Saudi Arabia.[Management and therapy of atrial fibrillation in geriatric patients].Dietary vitamin K intake and anticoagulation control during the initiation phase of warfarin therapy: a prospective cohort study.
P2860
Q36060109-13DD4931-8C60-4A95-BE2D-E2BEEBC04B5DQ36482270-9B3CD3C2-D532-42C3-AE7A-9BF86E180A5DQ37845262-06097D16-127E-4909-A955-6ABB8500921FQ38021821-49B8A658-376C-4462-A377-CD3E630587FFQ38163036-B61EA3BF-2FD3-45CA-A5ED-B0B427ECA588Q38655951-57ED21A6-1A06-4E51-A699-45B46B6BE11AQ38689603-F016F48F-E39D-4E3C-A088-7CAB2745B191Q39561868-B08A28D2-FC1F-4EB5-B1D4-F73D830D5639Q41997375-0E837116-B456-4D16-99CC-31A59B6C4006Q45912217-38FCC03A-2201-4A92-91D8-F5EFB83FD448Q47396715-4311B5DA-0699-4217-A02C-B95F7D4F465BQ48063492-838368CA-AFC5-4679-97E1-21E7FFB76465Q48510673-FE0EDFFE-0776-4C60-84FD-DBBB600BB4BCQ54184682-39F28046-F222-429A-B10A-B7A8557E8033Q55638380-87E4BE22-5508-44B4-9690-961763CC6B2B
P2860
Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Can we predict daily adherence ...... and Genetics (IN-RANGE) Study
@ast
Can we predict daily adherence ...... and Genetics (IN-RANGE) Study
@en
type
label
Can we predict daily adherence ...... and Genetics (IN-RANGE) Study
@ast
Can we predict daily adherence ...... and Genetics (IN-RANGE) Study
@en
prefLabel
Can we predict daily adherence ...... and Genetics (IN-RANGE) Study
@ast
Can we predict daily adherence ...... and Genetics (IN-RANGE) Study
@en
P2093
P2860
P356
P1433
P1476
Can we predict daily adherence ...... and Genetics (IN-RANGE) Study
@en
P2093
A Russell Localio
Abigail Cohen
Alec B Platt
Brian L Strom
Catherine S Parker
Colleen M Brensinger
Craig W Newcomb
Dean G Cruess
Jason D Christie
Joshua P Metlay
P2860
P304
P356
10.1378/CHEST.09-0039
P407
P577
2009-11-10T00:00:00Z